Stephens Kristin
Syros Pharmaceuticals, Inc. · Chief Development Officer
Stephens Kristin is listed in filings as Chief Development Officer at Syros Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Nov 20, 2024, including sale activity. Recent filings connect the profile to Syros Pharmaceuticals, Inc. (SYRS). The current snapshot covers public activity from Nov 4, 2024 to Nov 20, 2024. Reported amounts are shown as $7.9K to $12.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||